Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Andersen

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Toxicology and Applied Pharmacology|August 1, 1990
Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxaneR H Reitz, P S McCroskey, C N Park, et al.
Regulatory Toxicology and Pharmacology : RTP|May 4, 2020
Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring dataS Ramoju, M E Andersen, A Nong, et al.
Toxicology and Applied Pharmacology|November 1, 1990
Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphateJ M Gearhart, G W Jepson, H J Clewell, et al.
Toxicology Letters|July 1, 1990
In vivo metabolic interactions of benzene and tolueneK J Purcell, G H Cason, M L Gargas, et al.
Environmental Health Perspectives|December 1, 1994
Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate estersJ M Gearhart, G W Jepson, H J Clewell, et al.
Toxicology and Applied Pharmacology|May 1, 1997
Glutathione S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium: contrasting results with bromodichloromethane off chloroformR A Pegram, M E Andersen, S H Warren, et al.
The Science of the Total Environment|July 17, 2001
Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK modelH J Clewell, P R Gentry, J M Gearhart, et al.
Chemosphere|July 1, 1995
Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethyleneH J Clewell, P R Gentry, J M Gearhart, et al.
Toxicology and Applied Pharmacology|April 1, 1996
Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic modelR H Reitz, M L Gargas, M E Andersen, et al.
The Journal of Toxicological Sciences|May 1, 1987
Research strategy in industrial toxicologyP G Watanabe, T R Fox, R H Reitz, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Toxicology and Applied Pharmacology|August 1, 1990
Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxaneR H Reitz, P S McCroskey, C N Park, et al.
Regulatory Toxicology and Pharmacology : RTP|May 4, 2020
Derivation of whole blood biomonitoring equivalents for titanium for the interpretation of biomonitoring dataS Ramoju, M E Andersen, A Nong, et al.
Toxicology and Applied Pharmacology|November 1, 1990
Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphateJ M Gearhart, G W Jepson, H J Clewell, et al.
Toxicology Letters|July 1, 1990
In vivo metabolic interactions of benzene and tolueneK J Purcell, G H Cason, M L Gargas, et al.
Environmental Health Perspectives|December 1, 1994
Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate estersJ M Gearhart, G W Jepson, H J Clewell, et al.
Toxicology and Applied Pharmacology|May 1, 1997
Glutathione S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium: contrasting results with bromodichloromethane off chloroformR A Pegram, M E Andersen, S H Warren, et al.
The Science of the Total Environment|July 17, 2001
Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK modelH J Clewell, P R Gentry, J M Gearhart, et al.
Chemosphere|July 1, 1995
Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethyleneH J Clewell, P R Gentry, J M Gearhart, et al.
Toxicology and Applied Pharmacology|April 1, 1996
Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic modelR H Reitz, M L Gargas, M E Andersen, et al.
The Journal of Toxicological Sciences|May 1, 1987
Research strategy in industrial toxicologyP G Watanabe, T R Fox, R H Reitz, et al.
Pageof 18